Report cover image

Europe Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Country and Growth Forecast, 2023 - 2030

Publisher Knowledge Based Value (KBV) Research
Published Oct 31, 2023
Length 175 Pages
SKU # KBV18339151

Description

Europe Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Country and Growth Forecast, 2023 - 2030


The Europe Multiomics Market would witness market growth of 14.6% CAGR during the forecast period (2023-2030).

Tumor heterogeneity, the presence of diverse cell populations within a single tumor, is a significant challenge in cancer treatment. Multiomics data integration enables the comprehensive characterization of intra-tumours heterogeneity, helping researchers understand the genomic, transcriptomic, and proteomic differences between tumor cell subpopulations. For instance, in breast cancer, multiomics analysis has revealed that tumors can exhibit significant heterogeneity in gene expression, protein profiles, and genetic mutations. This understanding has led to the development of therapies that target multiple aspects of tumor heterogeneity, increasing the likelihood of treatment success.

Personalized medicine leverages this data to tailor treatment approaches to an individual's genetic, transcriptomic, and proteomic profile, maximizing therapeutic efficacy and minimizing adverse effects. It aids in the development of crops with increased nutritional value, pest and disease resistance, and yield. In the agri-food sector, it is used for quality control, traceability, and food safety. It is crucial for optimizing bioprocesses, leading to increased production of biofuels, pharmaceuticals, and industrial enzymes. In synthetic biology, multiomics data guides the design of synthetic organisms for various purposes, including bioremediation and biosensors.

The adoption of multiomics approaches has steadily increased across various domains, driven by the need for more comprehensive and data-rich insights into complex biological systems. Developing high-throughput sequencing, mass spectrometry, and other omics technologies has made it cost-effective and feasible to generate large-scale multiomics datasets. Increasing computational power and developing sophisticated bioinformatics tools enable the storage, analysis, and interpretation of multiomics data on a previously unimaginable scale. The proliferation of open-access biological databases facilitates the collection, storage, and retrieval of multiomics data, making it a valuable resource for researchers.

As per the data provided by the International Trade Administration, the Italian biotech industry is expanding, with a revenue of $12.3 billion in 2020. The majority of businesses, 376 out of 777, or 48%, are in the red biotech (life sciences) category. Pharmaceutical and medical device biotech businesses contribute 74% of the turnover with expanded research in diagnosis and cutting-edge therapies. There are over 200 cutting-edge start-ups, as well as roughly 100 public research institutions, university labs, and 47 scientific and research hospitals (IRCCS). Therefore, increased investment in the biotech industry in Europe will help in the expansion of the market in the region.

The Germany market dominated the Europe Multiomics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $370.5 million by 2030. The UK market is exhibiting a CAGR of 13.6% during (2023 - 2030). Additionally, The France market would experience a CAGR of 15.4% during (2023 - 2030).

Based on Type, the market is segmented into Bulk Multiomics, and Single-cell Multiomics. Based on Product & Service, the market is segmented into Product (Instruments, Consumables, and Software), and Services. Based on End-use, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others. Based on Platform, the market is segmented into Genomics, Transcriptomics, Proteomics, Metabolomics, and Integrated Omics Platforms. Based on Application, the market is segmented into Cell Biology, Oncology, Neurology, and Immunology. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc, Illumina, Inc., Danaher Corporation, PerkinElmer, Inc., Bruker Corporation, Qiagen N.V., Agilent Technologies, Inc., BGI Group, Becton, Dickinson, and Company, Shimadzu Corporation

Scope of the Study

Market Segments covered in the Report:

By Type
  • Bulk Multiomics
  • Single-cell Multiomics
By Product & Service
  • Product
  • Instruments
  • Consumables
  • Software
  • Services
By End-use
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others
By Platform
  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Integrated Omics Platforms
By Application
  • Cell Biology
  • Oncology
  • Neurology
  • Immunology
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Thermo Fisher Scientific, Inc
  • Illumina, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Bruker Corporation
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • BGI Group
  • Becton, Dickinson, and Company
  • Shimadzu Corporation
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

175 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Multiomics Market, by Type
1.4.2 Europe Multiomics Market, by Product & Service
1.4.3 Europe Multiomics Market, by End-use
1.4.4 Europe Multiomics Market, by Platform
1.4.5 Europe Multiomics Market, by Application
1.4.6 Europe Multiomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jun – 2023, Mar) Leading Players
4.4 Porter’s Five Force Analysis
Chapter 5. Europe Multiomics Market by Type
5.1 Europe Bulk Multiomics Market by Country
5.2 Europe Single-cell Multiomics Market by Country
Chapter 6. Europe Multiomics Market by Product & Service
6.1 Europe Product Market by Country
6.2 Europe Multiomics Market by Product Type
6.2.1 Europe Instruments Market by Country
6.2.2 Europe Consumables Market by Country
6.2.3 Europe Software Market by Country
6.3 Europe Services Market by Country
Chapter 7. Europe Multiomics Market by End-use
7.1 Europe Academic & Research Institutes Market by Country
7.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
7.3 Europe Others Market by Country
Chapter 8. Europe Multiomics Market by Platform
8.1 Europe Genomics Market by Country
8.2 Europe Transcriptomics Market by Country
8.3 Europe Proteomics Market by Country
8.4 Europe Metabolomics Market by Country
8.5 Europe Integrated Omics Platforms Market by Country
Chapter 9. Europe Multiomics Market by Application
9.1 Europe Cell Biology Market by Country
9.2 Europe Oncology Market by Country
9.3 Europe Neurology Market by Country
9.4 Europe Immunology Market by Country
Chapter 10. Europe Multiomics Market by Country
10.1 Germany Multiomics Market
10.1.1 Germany Multiomics Market by Type
10.1.2 Germany Multiomics Market by Product & Service
10.1.2.1 Germany Multiomics Market by Product Type
10.1.3 Germany Multiomics Market by End-use
10.1.4 Germany Multiomics Market by Platform
10.1.5 Germany Multiomics Market by Application
10.2 UK Multiomics Market
10.2.1 UK Multiomics Market by Type
10.2.2 UK Multiomics Market by Product & Service
10.2.2.1 UK Multiomics Market by Product Type
10.2.3 UK Multiomics Market by End-use
10.2.4 UK Multiomics Market by Platform
10.2.5 UK Multiomics Market by Application
10.3 France Multiomics Market
10.3.1 France Multiomics Market by Type
10.3.2 France Multiomics Market by Product & Service
10.3.2.1 France Multiomics Market by Product Type
10.3.3 France Multiomics Market by End-use
10.3.4 France Multiomics Market by Platform
10.3.5 France Multiomics Market by Application
10.4 Russia Multiomics Market
10.4.1 Russia Multiomics Market by Type
10.4.2 Russia Multiomics Market by Product & Service
10.4.2.1 Russia Multiomics Market by Product Type
10.4.3 Russia Multiomics Market by End-use
10.4.4 Russia Multiomics Market by Platform
10.4.5 Russia Multiomics Market by Application
10.5 Spain Multiomics Market
10.5.1 Spain Multiomics Market by Type
10.5.2 Spain Multiomics Market by Product & Service
10.5.2.1 Spain Multiomics Market by Product Type
10.5.3 Spain Multiomics Market by End-use
10.5.4 Spain Multiomics Market by Platform
10.5.5 Spain Multiomics Market by Application
10.6 Italy Multiomics Market
10.6.1 Italy Multiomics Market by Type
10.6.2 Italy Multiomics Market by Product & Service
10.6.2.1 Italy Multiomics Market by Product Type
10.6.3 Italy Multiomics Market by End-use
10.6.4 Italy Multiomics Market by Platform
10.6.5 Italy Multiomics Market by Application
10.7 Rest of Europe Multiomics Market
10.7.1 Rest of Europe Multiomics Market by Type
10.7.2 Rest of Europe Multiomics Market by Product & Service
10.7.2.1 Rest of Europe Multiomics Market by Product Type
10.7.3 Rest of Europe Multiomics Market by End-use
10.7.4 Rest of Europe Multiomics Market by Platform
10.7.5 Rest of Europe Multiomics Market by Application
Chapter 11. Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 SWOT Analysis
11.2 Illumina, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Product Launches and Product Expansions:
11.2.5.3 Acquisition and Mergers:
11.2.5.4 Geographical Expansions:
11.2.6 SWOT Analysis
11.3 Danaher Corporation
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 SWOT Analysis
11.4 PerkinElmer, Inc.
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Bruker Corporation
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Product Launches and Product Expansions:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Qiagen N.V.
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Agilent Technologies, Inc.
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Partnerships, Collaborations, and Agreements:
11.7.6 SWOT Analysis
11.8 BGI Group
11.8.1 Company Overview
11.8.2 Recent strategies and developments:
11.8.2.1 Partnerships, Collaborations, and Agreements:
11.8.3 SWOT Analysis
11.9 Becton, Dickinson, and Company
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.9.4.1 Product Launches and Product Expansions:
11.9.5 SWOT Analysis
11.10. Shimadzu Corporation
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Segmental and Regional Analysis
11.10.4 Research & Development Expense
11.10.5 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us